Literature DB >> 12759254

Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis.

Guillermo Fernández-Varo1, Josefa Ros, Manuel Morales-Ruiz, Pilar Cejudo-Martín, Vicente Arroyo, Manel Solé, Francisca Rivera, Juan Rodés, Wladimiro Jiménez.   

Abstract

Vascular remodeling is an active process that consists in important modifications in the vessel wall. Endothelium-derived nitric oxide (NO) plays a major role in this phenomenon. We assessed wall thickness (WT), total wall area (TWA), lumen diameter, and total nuclei number/cross-section (TN) in cirrhotic rats with ascites and in control rats. A second group of cirrhotic rats received the NO synthesis inhibitor, L-NAME, or vehicle daily for 11 weeks and systemic hemodynamics, arterial compliance, aortic NO synthase 3 (NOS3) protein expression, and vascular morphology were analyzed. Cirrhotic vessels showed a significant reduction in WT, TWA, and TN as compared to control vessels. Long-term inhibition of NOS activity in cirrhotic rats resulted in a significant increase in WT, TWA, and TN as compared to cirrhotic rats receiving vehicle. NOS3 protein abundance was higher in aortic vessels of nontreated cirrhotic animals than in controls. This difference was abolished by chronic treatment with L-NAME. NOS inhibition in cirrhotic rats resulted in higher arterial pressure and peripheral resistance and lower arterial compliance than cirrhotic rats receiving vehicle. Therefore, vascular remodeling in cirrhosis with ascites is a generalized process with significant functional consequences that can be negatively modulated by long-term inhibition of NOS activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759254      PMCID: PMC1868141          DOI: 10.1016/S0002-9440(10)64331-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites.

Authors:  J Clària; W Jiménez; J Ros; M Rigol; P Angeli; V Arroyo; F Rivera; J Rodés
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

Review 2.  The emerging concept of vascular remodeling.

Authors:  G H Gibbons; V J Dzau
Journal:  N Engl J Med       Date:  1994-05-19       Impact factor: 91.245

Review 3.  Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.

Authors:  V Arroyo; W Jiménez
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

4.  Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation.

Authors:  T J McCabe; D Fulton; L J Roman; W C Sessa
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

5.  Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats.

Authors:  M Niederberger; P Y Martin; P Ginès; K Morris; P Tsai; D L Xu; I McMurtry; R W Schrier
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

6.  Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP.

Authors:  T L Cornwell; E Arnold; N J Boerth; T M Lincoln
Journal:  Am J Physiol       Date:  1994-11

7.  Nitric oxide production in arterial vessels of cirrhotic rats.

Authors:  J Ros; W Jiménez; S Lamas; J Clària; V Arroyo; F Rivera; J Rodés
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

8.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

Authors:  C B Treasure; J L Klein; W S Weintraub; J D Talley; M E Stillabower; A S Kosinski; J Zhang; S J Boccuzzi; J C Cedarholm; R W Alexander
Journal:  N Engl J Med       Date:  1995-02-23       Impact factor: 91.245

9.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

Authors:  H E von der Leyen; G H Gibbons; R Morishita; N P Lewis; L Zhang; M Nakajima; Y Kaneda; J P Cooke; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  Nitric oxide activates metalloprotease enzymes in articular cartilage.

Authors:  G A Murrell; D Jang; R J Williams
Journal:  Biochem Biophys Res Commun       Date:  1995-01-05       Impact factor: 3.575

View more
  13 in total

1.  Morphological and biomechanical remodelling of the hepatic artery in a swine model of portal hypertension.

Authors:  Xi-Ju He; Ming-Hua Yu; Wen-Chun Li; Han-Qin Wang; Jing Li; Xing-Chun Peng; Jie Tang; Na Feng; Tie-Zhu Huang
Journal:  Hepatol Int       Date:  2011-09-23       Impact factor: 6.047

Review 2.  Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  Liver Int       Date:  2011-07-05       Impact factor: 5.828

Review 3.  Pathophysiology of portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  Clin Liver Dis       Date:  2014-02-25       Impact factor: 6.126

Review 4.  Management of hepatorenal syndrome in patients with cirrhosis.

Authors:  Vicente Arroyo; Javier Fernández
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

5.  Prevalence of arterial hypertension in cirrhosis of liver.

Authors:  Prabhu P Rajesh; R Srinivasan; V Jayanthi
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

Review 6.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

Review 7.  Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.

Authors:  Yasuko Iwakiri; Vijay Shah; Don C Rockey
Journal:  J Hepatol       Date:  2014-06-06       Impact factor: 25.083

8.  Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics.

Authors:  J H Henriksen; S Fuglsang; F Bendtsen; S Møller
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

9.  Proteomic identification of S-nitrosylated Golgi proteins: new insights into endothelial cell regulation by eNOS-derived NO.

Authors:  Panjamaporn Sangwung; Todd M Greco; Yanzhuang Wang; Harry Ischiropoulos; William C Sessa; Yasuko Iwakiri
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 10.  Hemodynamic alterations in cirrhosis and portal hypertension.

Authors:  Moon Young Kim; Soon Koo Baik; Samuel S Lee
Journal:  Korean J Hepatol       Date:  2010-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.